EastBridge Investment Group Corporation (EBIG) announced that on February 6 EBIG and Cellular Biomedicine Group (CBMG), which is incorporated in the British Virgin Islands, signed all the documents and filed the Articles of Merger with the Registry of Corporate Affairs of the British Virgin Islands, with respect to the consummation of merger of CBMG with CBMG Acquisition Limited, another BVI company and a wholly-owned subsidiary of EBIG.
The merged entity is the wholly-owned subsidiary of EBIG, which continues operations under its name, and it common stock continues to be quoted under stock symbol EBIGD.
Cellular Biomedicine Group, Ltd. is focused on developing cell therapies for the treatment of cancer and degenerative diseases. Company’s scientists make cellular research, currently developing biomedicine based on tissue-derived progenitor cells, embryonic stem (ES) cells and cancer-specific dendritic cells.
EastBridge Investment Group focuses on high-growth companies in Asia and in the United States, offering assistance with all aspects of IPOs, joint ventures and merchant banking services, targeting industries in the fields of electronics, real estate, auto, metal, energy, environmental, bioscience and retail food distribution.
Showing posts with label Reverse Mergers. Show all posts
Showing posts with label Reverse Mergers. Show all posts
Wednesday, February 13, 2013
Monday, July 20, 2009
BVI-based company Megaway International Holdings finalizes reverse merger
BTHC VIII, a total solution provider of heat exchangers in China, announced the closing of a share exchange transaction with the shareholder of the British Virgin Islands corporation Megaway International Holdings.
In the share exchange transaction, BVI company's shareholder was issued 14,800,000 shares of common stock of BTHC VIII, which makes approximately 92.5 percent of the total issued and outstanding capital stock of the company, in exchange for 100 per cent of the issued and outstanding shares of Megaway. As a result of the deal, Megaway has become a wholly-owned subsidiary of the company.
Upon the closing of the share exchange, BTHC's executive officers were replaced by the executive officers of the BVI registered Megaway and its subsidiaries. The company plans to change its name to THT Heat Transfer Technology.
In the share exchange transaction, BVI company's shareholder was issued 14,800,000 shares of common stock of BTHC VIII, which makes approximately 92.5 percent of the total issued and outstanding capital stock of the company, in exchange for 100 per cent of the issued and outstanding shares of Megaway. As a result of the deal, Megaway has become a wholly-owned subsidiary of the company.
Upon the closing of the share exchange, BTHC's executive officers were replaced by the executive officers of the BVI registered Megaway and its subsidiaries. The company plans to change its name to THT Heat Transfer Technology.
Monday, May 18, 2009
Chinese medicine company completes reverse merger with BVI holding group
On May 7, 2009, Domain Registration Corp., which is now in the process of changing its name into BioPharm Asia, Inc., acquired all of the outstanding capital stock of the British Virgin Islands-based China Northern Pharmacy Holding Group Limited (CNPH). The company has preliminarily completed the integration of industry chain, extending the sole trading business (including terminal chain stores, distribution and wholesale business). The Board of Directors of Domain Registration Corp. has adopted certain amendments, which include name change to BioPharm Asia, Inc., which shall become effective upon shareholder approval and the supply of information to the SEC.
BVI-registered CNPH is a holding company that acquired all of the outstanding stock of China Northern Pharmacy Holding Group Limited based in Hong Kong (CNPH HK), the company that owns two operating subsidiaries focused on pharmaceutical logistics and distribution as well as the sale of herbal products throughout China. Through these two wholly-owned subsidiaries, Domain Registration Corp. is planning to create a comprehensive pharmaceutical company in China, and an integrated industry chain.
The company which will be named BioPharm Asia intends to further include into its business Tibetan pharmacies, healthcare and medicine delivery services.
Future BioPharm Asia held a press conference concerning the successful reverse merger, which was attended by some institutional investors and investment banks from the United States, and entrepreneurs from approximately 50 well-known Chinese pharmaceutical companies, medicine distributors and pharmacy chains.
BVI-registered CNPH is a holding company that acquired all of the outstanding stock of China Northern Pharmacy Holding Group Limited based in Hong Kong (CNPH HK), the company that owns two operating subsidiaries focused on pharmaceutical logistics and distribution as well as the sale of herbal products throughout China. Through these two wholly-owned subsidiaries, Domain Registration Corp. is planning to create a comprehensive pharmaceutical company in China, and an integrated industry chain.
The company which will be named BioPharm Asia intends to further include into its business Tibetan pharmacies, healthcare and medicine delivery services.
Future BioPharm Asia held a press conference concerning the successful reverse merger, which was attended by some institutional investors and investment banks from the United States, and entrepreneurs from approximately 50 well-known Chinese pharmaceutical companies, medicine distributors and pharmacy chains.
Thursday, December 27, 2007
BVI-controlled Rise & Grow Limited merges with Dexterity Surgical, Inc.
Dexterity Surgical, Inc. has announced the completion of a reverse merger with Hong Kong holding company Rise & Grow Limited, which is controlled by the British Virgin Islands company Newise Century Inc. To finilize the transaction, 26,400,000 common shares newly issued by Dexterity Surgical, Inc. (that is 66% of Dexterity Surgical’s 40,000,000 issued and outstanding shares) were issued to the BVI company, which is the sole shareholder of Rise & Grow.
Rise & Grow’ sole operating entity is Zhi Bao Da Tong (Beijing) Technology Co. Ltd. – a company formed under the law of the People’s Republic of China as a wholly foreign-owned enterprise doing business on the Chinese territory. After the transaction is closed, the operations of the Chinese company will become the only operations of Dexterity Surgical, Inc.
Rise & Grow’ sole operating entity is Zhi Bao Da Tong (Beijing) Technology Co. Ltd. – a company formed under the law of the People’s Republic of China as a wholly foreign-owned enterprise doing business on the Chinese territory. After the transaction is closed, the operations of the Chinese company will become the only operations of Dexterity Surgical, Inc.
Thursday, October 25, 2007
Yanglin Group acquired by Victory Divide Mining through BVI-domiciled Faith Winner Investment Ltd
Victory Divide Mining company has reported about the acquisition of Faith Winner Investment Limited, which is registered in the British Virgin Islands. The announced deal took place on October 3, 2007.
BVI-domiciled corporation, through a Chinese-based Faith Winner (Jixian) Agriculture Development Company, has a series of contracts with Heilongjiang Yanglin Soybean Group Co. Ltd, which gives it control over Yanglin's finances and business, - manufacturing and selling non-genetically modified soybean products, - as if it were a wholly owned subsidiary of the BVI company. Over the past two years, Yanglin's business has grown significantly, with revenues increasing to $88,078,494 for the fiscal year ended December 31, 2006, from $38,395,505 for the prior year.
The CEO of the Victory Divide Mining company, Shulin Liu, commented on the deal that “The closing of our reverse merger transaction and financing provide us with the capital investment we need to not only continue the growth of Yanglin's business, but to accelerate that growth. We can now focus on meeting existing demand for our products, as well as accelerating marketing efforts to increase our market share both in the PRC and abroad."
Also, on the same date Victory Divide Mining company completed a private placement of $21.5 million through the sale of share of its Series A Convertible Preferred Stock and attached warrants.
BVI-domiciled corporation, through a Chinese-based Faith Winner (Jixian) Agriculture Development Company, has a series of contracts with Heilongjiang Yanglin Soybean Group Co. Ltd, which gives it control over Yanglin's finances and business, - manufacturing and selling non-genetically modified soybean products, - as if it were a wholly owned subsidiary of the BVI company. Over the past two years, Yanglin's business has grown significantly, with revenues increasing to $88,078,494 for the fiscal year ended December 31, 2006, from $38,395,505 for the prior year.
The CEO of the Victory Divide Mining company, Shulin Liu, commented on the deal that “The closing of our reverse merger transaction and financing provide us with the capital investment we need to not only continue the growth of Yanglin's business, but to accelerate that growth. We can now focus on meeting existing demand for our products, as well as accelerating marketing efforts to increase our market share both in the PRC and abroad."
Also, on the same date Victory Divide Mining company completed a private placement of $21.5 million through the sale of share of its Series A Convertible Preferred Stock and attached warrants.
Subscribe to:
Posts (Atom)